Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy-Reference-Cited by-同舟云学术

Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy

Author:

Aziz Aisha¹,Rehman Urushi¹,Sheikh Afsana¹,Abourehab Mohammed A. S.²³,Kesharwani Prashant¹⁴^ORCID

Affiliation:

1. Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

2. Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia

3. Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Minia University, Minia, Egypt

4. University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India

Funder

Deanship of Scientific Research at Umm Al-Qura University

Indian Council of Medical Research (ICMR),

Publisher

Informa UK Limited

Subject

Biomedical Engineering,Biomaterials,Bioengineering,Biophysics

Link

Reference97 articles.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献